Eslicarbazepine Acetate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 67877-585
  • Package NDC 67877-585-30
  • Application number ANDA211199
  • SPL ID ca4bcb9f-157d-4d49-92f5-6b76745aabe1
  • SPL set ID 28efe9d2-9d7b-4a7c-8458-098456d06604
  • UNII BEA68ZVB2K
  • RxCUI 1482507
  • RxCUI 1482515
  • RxCUI 1482521
  • RxCUI 1482525

What the source publishes

Labeler
Ascend Laboratories, LLC
Active ingredients
Eslicarbazepine Acetate
Form
TABLET
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:67877-585_ca4bcb9f-157d-4d49-92f5-6b76745aabe1
{
  "name": "Eslicarbazepine Acetate",
  "splId": "ca4bcb9f-157d-4d49-92f5-6b76745aabe1",
  "labels": [
    {
      "setId": "28efe9d2-9d7b-4a7c-8458-098456d06604",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=28efe9d2-9d7b-4a7c-8458-098456d06604",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=28efe9d2-9d7b-4a7c-8458-098456d06604"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Ascend Laboratories, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BOTTLE (67877-585-30)",
      "package_ndc": "67877-585-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250506"
    }
  ],
  "productId": "67877-585_ca4bcb9f-157d-4d49-92f5-6b76745aabe1",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "67877-585",
  "deaSchedule": null,
  "genericName": "Eslicarbazepine Acetate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ESLICARBAZEPINE ACETATE",
      "strength": "200 mg/1"
    }
  ],
  "applicationNumber": "ANDA211199",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250506",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0367877588308",
      "0367877586304",
      "0367877585307"
    ],
    "unii": [
      "BEA68ZVB2K"
    ],
    "rxcui": [
      "1482507",
      "1482515",
      "1482521",
      "1482525"
    ],
    "spl_set_id": [
      "28efe9d2-9d7b-4a7c-8458-098456d06604"
    ],
    "manufacturer_name": [
      "Ascend Laboratories, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:67877-585_ca4bcb9f-157d-4d49-92f5-6b76745aabe1"